Connection
Heather Gilmartin to Glucagon-Like Peptide 1
This is a "connection" page, showing publications Heather Gilmartin has written about Glucagon-Like Peptide 1.
|
|
Connection Strength |
|
 |
|
 |
|
0.052 |
|
|
|
-
Salahuddin T, Hebbe A, Daus M, Essien UR, Waldo SW, Rodriguez F, Ho PM, Simons C, Gilmartin HM, Doll JA. Trends and site-level variation of novel cardiovascular medication utilization among patients admitted for heart failure or coronary artery disease in the US Veterans Affairs System: 2017-2021. Am Heart J. 2024 02; 268:68-79.
Score: 0.052